Singapore: Scientists from A*STAR's Bioprocessing Technology Institute (BTI) have identified relationship between two ce...
Singapore: Thomson Medical Center (TMC) in Singapore has installed Cadi SmartSense Infant Safety Solution (Gen II), a ra...
Singapore: Stratasys, 3D printing solutions provider, has launched a 3D printing experience centre in Singapore to provi...
Singapore: VolitionRx, focused on developing blood-based diagnostic tests for a broad range of cancer types and other co...
We do see a strong trend towards movement of sensitive products, particularly the temperature sensitive products. This i...
Singapore: A key challenge in virus-based gene therapy is avoiding detection by the human immune system, so that the vir...
Singapore: Though the south east Asian people are considered to be the thinnest in the world, there is an exponential in...
Singapore: Novartis' novel antimalarial drug, KAE609 (cipargamin) has shown efficacy in Phase 2 trial by demonstrating t...
Singapore: Singapore's Agency for Science, Technology and Research (A*STAR) and global healthcare company, GE Healthcare...
Mr Michael Tillmann has been the president and CEO of global pharmaceutical company, Roche Diagnostics, and has played l...
During the year 2012, the bioscience industry in the Asia Pacific region clocked $154.40 billion in revenues, recording ...
Singapore: Compared to other countries in ASEAN, Malaysia has a higher-than-average availability of medical personnel an...
Singapore: Pharmaceutical company, Mundipharma, has derived positive results from its Betadine formulations, used for sk...
Singapore: Scientists from Singapore's Institute of Molecular and Cell Biology (IMCB), a research institute under the Ag...
Singapore: Bruker, global manufacturer of scientific instruments for molecular research, has opened its Preclinical Imag...
Singapore: A team of scientists at National University of Singapore (NUS) have discovered that a drug originally designe...
Singapore: ASLAN Pharmaceuticals, Singapore based biotech company focused on the development of immunotherapies and targ...
Singapore: Singapore and Germany based biotech company, AYOXXA Biosystems, has completed $12.28 million (€9 millio...
